BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22322139)

  • 1. Cerebral thrombosis in patients with β-thalassemia: a systematic review.
    Haghpanah S; Karimi M
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):212-7. PubMed ID: 22322139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein C levels in beta-thalassemia major patients in the east Nile delta of Egypt.
    Hassan TH; Elbehedy RM; Youssef DM; Amr GE
    Hematol Oncol Stem Cell Ther; 2010; 3(2):60-5. PubMed ID: 20543538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercoagulable state in five thalassemia intermedia patients.
    Bhattacharyya M; Kannan M; Chaudhry VP; Mahapatra M; Pati H; Saxena R
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):422-7. PubMed ID: 17911195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercoagulable state as demonstrated by thromboelastometry in hemoglobin E/beta-thalassemia patients: Association with clinical severity and splenectomy status.
    Natesirinilkul R; Charoenkwan P; Nawarawong W; Boonsri S; Tantivate P; Wongjaikum S; Manowong S; Sanguansermsri T
    Thromb Res; 2016 Apr; 140():125-131. PubMed ID: 26971311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation and splenectomy: an overview.
    Cappellini MD; Grespi E; Cassinerio E; Bignamini D; Fiorelli G
    Ann N Y Acad Sci; 2005; 1054():317-24. PubMed ID: 16339680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypercoagulable state in thalassemia intermedia.
    Taher AT; Musallam KM; Inati A
    Hemoglobin; 2009; 33 Suppl 1():S160-9. PubMed ID: 20001621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenectomy and thrombosis: the case of thalassemia intermedia.
    Taher AT; Musallam KM; Karimi M; El-Beshlawy A; Belhoul K; Daar S; Saned M; Cesaretti C; Cappellini MD
    J Thromb Haemost; 2010 Oct; 8(10):2152-8. PubMed ID: 20546125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrovascular accident in beta-thalassemia major (beta-TM) and beta-thalassemia intermedia (beta-TI).
    Karimi M; Khanlari M; Rachmilewitz EA
    Am J Hematol; 2008 Jan; 83(1):77-9. PubMed ID: 17696211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein C and S levels in patients with Thalassemia intermedia.
    Mohammed NS
    J Med Life; 2022 Nov; 15(11):1415-1418. PubMed ID: 36567848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricuspid regurgitation in patients with beta-thalassemia major.
    Wu KH; Chang JS; Su BH; Peng CT
    Ann Hematol; 2004 Dec; 83(12):779-83. PubMed ID: 15449031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation and activation in thalassemia major patients in Indonesia.
    Setiabudy R; Wahidiyat PA; Setiawan L
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):346-51. PubMed ID: 18160592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of anticoagulant proteins and soluble endothelial protein C receptor in thalassemia patients of Chinese origin.
    Huang Y; Long Y; Deng D; Liu Z; Liang H; Sun N; Xu Y; Lai Y; Cheng P
    Thromb Res; 2018 Dec; 172():61-66. PubMed ID: 30384036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moyamoya syndrome in a splenectomized patient with beta-thalassemia intermedia.
    Sanefuji M; Ohga S; Kira R; Yoshiura T; Torisu H; Hara T
    J Child Neurol; 2006 Jan; 21(1):75-7. PubMed ID: 16551458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic risk in thalassemic patients.
    Moratelli S; De Sanctis V; Gemmati D; Serino ML; Mari R; Gamberini MR; Scapoli GL
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():915-21. PubMed ID: 10091165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silent cerebral infarct in child patients with beta thalassaemia intermedia.
    Leblebisatan G; Bay A; Sirikci A; Kilincaslan H; Sonmezisik S; Leblebisatan S; Baspinar O; Dogan M; Yis U
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):608-13. PubMed ID: 22918039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convulsion after blood transfusion in four beta-thalassemia intermedia patients.
    Gürgey A; Kalayci O; Gümrük F; Cetin M; Altay C
    Pediatr Hematol Oncol; 1994; 11(5):549-52. PubMed ID: 7826850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia.
    Taher AT; Musallam KM; Nasreddine W; Hourani R; Inati A; Beydoun A
    J Thromb Haemost; 2010 Jan; 8(1):54-9. PubMed ID: 19817994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping.
    Khalifa AS; Salem M; Mounir E; El-Tawil MM; El-Sawy M; Abd Al-Aziz MM
    Pediatr Diabetes; 2004 Sep; 5(3):126-32. PubMed ID: 15450007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical central nervous system involvement and thrombophilic status in young thalassemia intermedia patients of Greek origin.
    Teli A; Economou M; Rudolf J; Tzovaras F; Gourtsa V; Kondou A; Kontopoulos E; Gombakis N; Athanassiou-Metaxa M; Zafeiriou D
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):195-202. PubMed ID: 22322135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and distribution of asymptomatic brain lesions in patients with β-thalassemia intermedia.
    Karimi M; Haghpanah S; Bagheri MH; Bordbar MR; Pishdad P; Rachmilewitz EA
    Ann Hematol; 2012 Dec; 91(12):1833-8. PubMed ID: 22824997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.